EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

COST EFFECTIVENESS ANALYSIS OF ORAL COMBINATION DIABETES MELLITUS TREATMENT IN PATIENTS HOSPITALIZED IN HOSPITAL X

Nur Rahmi Hidayati, Indah Setyaningsih, Rinto Susilo, Lela Sulastri, Sulistiorini Indriaty, Nina Karlina, Yayan Rizikiyan, Atiqoh Rohmawati

Medical Sains : Jurnal Ilmiah Kefarmasian · 17.03.2026 · 11 (1) · 81-88

DOI: 10.37874/ms.v11i1.1839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sains : Jurnal Ilmiah Kefarmasian, online erschienen am 17.03.2026. Verfasst von Nur Rahmi Hidayati und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a serious, long-term condition that occurs when blood glucose levels rise due to the body's inability to use insulin effectively. Cost-effectiveness analysis is used to assess the relationship between resources (inputs) and clinical outcomes (outputs), thereby enabling the selection of effective and efficient therapies. This study aims to determine patient characteristics (gender, age, payment status, comorbidities, blood sugar levels), types of diabetes mellitus drug combinations and cost-effectiveness of treatment of diabetes mellitus patients at the X Hospital inpatient installation in 2023. This study was conducted using a non-experimental method with a descriptive design through a retrospective search. The samples used were 136 medical records and payment receipts for patients with DM at the X Hospital inpatient installation who met the inclusion criteria. The data collected were the direct medical costs of using oral combination antidiabetic drugs and the effectiveness parameters from blood glucose level tests with a target GDS of < 200 mg/dl. The results of the study based on the characteristics of the patients were mostly female (63.97%), aged 45-65 years (76.47%), average length of stay 5.5 days, BPJS Class III (76.48%), and GDS level discharged from hospital ? 200 mg/dl (97.06%). The most widely used combination of oral antidiabetic drugs was acarbose 100 mg + gliquidone 30 mg (55.15%). The combination of Metformin+Gliquidone is the most cost-effective combination, with an ACER value of Rp. 56,517.98, and an ICER value of Rp. 68,211.36 compared to the combinations of Acarbose+Gliquidone and Metformin+Glimepiride.

Zitieren

APA

Hidayati, N. R., Setyaningsih, I., Susilo, R., Sulastri, L., Indriaty, S., Karlina, N., Rizikiyan, Y., & Rohmawati, A. (2026). COST EFFECTIVENESS ANALYSIS OF ORAL COMBINATION DIABETES MELLITUS TREATMENT IN PATIENTS HOSPITALIZED IN HOSPITAL X. Medical Sains : Jurnal Ilmiah Kefarmasian, 11(1), 81-88. https://doi.org/10.37874/ms.v11i1.1839

Vancouver

Hidayati NR, Setyaningsih I, Susilo R, Sulastri L, Indriaty S, Karlina N, et al. COST EFFECTIVENESS ANALYSIS OF ORAL COMBINATION DIABETES MELLITUS TREATMENT IN PATIENTS HOSPITALIZED IN HOSPITAL X. Medical Sains : Jurnal Ilmiah Kefarmasian. 2026;11(1):81-88. doi:10.37874/ms.v11i1.1839

BibTeX
@article{Hidayati2026,
  author = {Hidayati, Nur Rahmi and Setyaningsih, Indah and Susilo, Rinto and Sulastri, Lela and Indriaty, Sulistiorini and Karlina, Nina and Rizikiyan, Yayan and Rohmawati, Atiqoh},
  title = {COST EFFECTIVENESS ANALYSIS OF ORAL COMBINATION DIABETES MELLITUS TREATMENT IN PATIENTS HOSPITALIZED IN HOSPITAL X},
  journal = {Medical Sains : Jurnal Ilmiah Kefarmasian},
  year = {2026},
  volume = {11},
  number = {1},
  pages = {81--88},
  doi = {10.37874/ms.v11i1.1839}
}
Kostenlos starten →